These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 35554591)

  • 21. Superior hypertension control with betablockade in the European Sleep Apnea Database.
    Svedmyr S; Hedner J; Zou D; Parati G; Ryan S; Hein H; Pepin JL; Tkáčová R; Marrone O; Schiza S; Basoglu OK; Grote L;
    J Hypertens; 2021 Feb; 39(2):292-301. PubMed ID: 33031170
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Deprescribing: an essential part of rational pharmacotherapy].
    Engi Z; Matuz M; Soós G; Hajnal F; Szökő É; Viola R; Csupor D; Benkő R
    Orv Hetil; 2023 Jun; 164(24):931-941. PubMed ID: 37330979
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relationship Between OSA and Hypertension.
    Torres G; Sánchez-de-la-Torre M; Barbé F
    Chest; 2015 Sep; 148(3):824-832. PubMed ID: 25879807
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A double-blind, crossover study of Doxazosin and Enalapril on peripheral vascular tone and nocturnal blood pressure in sleep apnea patients.
    Zou D; Grote L; Eder DN; Radlinski J; Hedner J
    Sleep Med; 2010 Mar; 11(3):325-8. PubMed ID: 20171140
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effects of in-hospital deprescribing on potential prescribing omission in hospitalized elderly patients with polypharmacy.
    Kaminaga M; Komagamine J; Tatsumi S
    Sci Rep; 2021 Apr; 11(1):8898. PubMed ID: 33903645
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Active deprescribing program in chronic kidney disease patients undergoing haemodialysis.
    George JS; Joseph R; Thomas ETA; John GP; Siby A; Nair MM
    Nephrology (Carlton); 2021 Nov; 26(11):890-897. PubMed ID: 34240512
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antihypertensive Deprescribing in Older Adult Veterans at End of Life Admitted to Veteran Affairs Nursing Homes.
    Vu M; Sileanu FE; Aspinall SL; Niznik JD; Springer SP; Mor MK; Zhao X; Ersek M; Hanlon JT; Gellad WF; Schleiden LJ; Thorpe JM; Thorpe CT
    J Am Med Dir Assoc; 2021 Jan; 22(1):132-140.e5. PubMed ID: 32723537
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Should antihypertensive agents be used in normotensive patients with obstructive sleep apnea?
    Myslinski W; Duchna HW; Mosiewicz J
    Minerva Med; 2005 Feb; 96(1):62-3. PubMed ID: 15827543
    [No Abstract]   [Full Text] [Related]  

  • 29. [Obstructive sleep apnea: clinical significance and correlations with arterial hypertension].
    Zelveian PA; Buniatian MS; Oshchepkova EV; Rogoza AN
    Klin Med (Mosk); 2002; 80(12):18-22. PubMed ID: 12638405
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Role of Patient Preferences in Deprescribing.
    Holmes HM; Todd A
    Clin Geriatr Med; 2017 May; 33(2):165-175. PubMed ID: 28364989
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Deprescribing as a Clinical Improvement Focus.
    Dharmarajan TS; Choi H; Hossain N; Munasinghe U; Lakhi F; Lourdusamy D; Onuoha S; Murakonda P; Skokowska-Lebelt A; Kanagala M; Russell RO
    J Am Med Dir Assoc; 2020 Mar; 21(3):355-360. PubMed ID: 31672564
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Barricades and brickwalls--a qualitative study exploring perceptions of medication use and deprescribing in long-term care.
    Palagyi A; Keay L; Harper J; Potter J; Lindley RI
    BMC Geriatr; 2016 Jan; 16():15. PubMed ID: 26767619
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antihypertensive therapy for patients with obstructive sleep apnea.
    Ziegler MG; Milic M; Sun P
    Curr Opin Nephrol Hypertens; 2011 Jan; 20(1):50-5. PubMed ID: 21326007
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nursing home team-care deprescribing study: a stepped-wedge randomised controlled trial protocol.
    Kua CH; Yeo CYY; Char CWT; Tan CWY; Tan PC; Mak VS; Lee SWH; Leong IY
    BMJ Open; 2017 May; 7(5):e015293. PubMed ID: 28490560
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Deprescribing in primary care in Portugal (DePil17-20): a three-phase observational and experimental study protocol.
    Simões PA; Santiago LM; Simões JA
    BMJ Open; 2018 Jul; 8(7):e019542. PubMed ID: 30018092
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Left ventricular geometry in patients with obstructive sleep apnea coexisting with treated systemic hypertension.
    Myslinski W; Duchna HW; Rasche K; Dichmann M; Mosiewicz J; Schultze-Werninghaus G
    Respiration; 2007; 74(2):176-83. PubMed ID: 16439828
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MediQuit, an Electronic Deprescribing Tool for Patients on Polypharmacy: Results of a Feasibility Study in German General Practice.
    Junius-Walker U; Viniol A; Michiels-Corsten M; Gerlach N; Donner-Banzhoff N; Schleef T
    Drugs Aging; 2021 Aug; 38(8):725-733. PubMed ID: 34251594
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Beliefs and attitudes of residents, family members and healthcare professionals regarding deprescribing in long-term care: a qualitative study.
    Rowe S; Pittman N; Balsom C; Druken R; Kelly DV
    Int J Clin Pharm; 2022 Dec; 44(6):1370-1379. PubMed ID: 36201111
    [TBL] [Abstract][Full Text] [Related]  

  • 39. What do older adults with multimorbidity and polypharmacy think about deprescribing? The LESS study - a primary care-based survey.
    Rozsnyai Z; Jungo KT; Reeve E; Poortvliet RKE; Rodondi N; Gussekloo J; Streit S
    BMC Geriatr; 2020 Oct; 20(1):435. PubMed ID: 33129274
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Deprescribing in nursing homes - which drugs and when?].
    Püllen R
    MMW Fortschr Med; 2023 Mar; 165(4):38-41. PubMed ID: 36826665
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.